Skip to content

Natacha Vanattou‐saïfoudine

3 papers in the library · 105 citations · publishing 2010-2012

Papers

Sort Most recent Most cited

Caffeine provokes adverse interactions with 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) and related psychostimulants: mechanisms and mediators

British Journal of Pharmacology June 1, 2012 Natacha Vanattou‐saïfoudine, Ruth Mcnamara, Andrew Harkin 60 citations

Concomitant consumption of caffeine with recreational psychostimulant drugs of abuse can provoke severe acute adverse reactions in addition to longer term consequences. The mechanisms by which caffeine increases the toxicity of psychostimulants include changes in body temperature regulation, cardiotoxicity and lowering of the seizure threshold. Caffeine also influences the stimulatory,...

Dopamine D1Receptor‐Mediated Intracellular Responses in the Hypothalamus after Co‐Administration of Caffeine with MDMA

Basic & Clinical Pharmacology & Toxicology October 4, 2011 Natacha Vanattou‐saïfoudine, Brendan Behan, Andrew Harkin 6 citations

Markers of dopamine D(1) receptor activation were determined to elucidate intracellular mechanisms associated with the combined effects of caffeine and 3,4 methylenedioxymethamphetamine (MDMA), reported previously to produce increased toxicity, when compared with either drug alone. Caffeine (10 mg/kg) and MDMA (15 mg/kg) were administered to male Sprague Dawley rats alone and in combination....

Mechanisms mediating the ability of caffeine to influence MDMA (‘Ecstasy’)‐induced hyperthermia in rats

British Journal of Pharmacology May 24, 2010 Natacha Vanattou‐saïfoudine, Ruth Mcnamara, Andrew Harkin 39 citations

Background and purpose: Caffeine exacerbates the hyperthermia associated with an acute exposure to 3,4 methylenedioxymethamphetamine (MDMA, ‘Ecstasy’) in rats. The present study investigated the mechanisms mediating this interaction. Experimental approach: Adult male Sprague‐Dawley rats were treated with caffeine (10 mg·kg −1 ; i.p.) and MDMA (15 mg·kg −1 ; i.p.) alone and in combination. Core...

DOI: 10.1111/j.1476-5381.2010.00660.x (opens in new tab) MDMA Sch-23390 Pharmacology Receptor antagonist +4